Key result
Anti-HCV positivity is linked to lower HRQOL driven by host and environmental factors, not HCV RNA.
Why the study?
Hepatitis C virus infection is associated with decreased health-related quality of life, but the relative impact of host, disease, and viral factors is unclear.
Cross-Sectional (n=833)
In patients with HCV infection, decreased health-related quality of life is driven by host and environmental factors rather than viral factors.
Host factors like income and comorbidities, not viremia, primarily impair HRQOL in anti-HCV subjects; hypothesis-generating for non-viral interventions pending prospective data.
BACKGROUND: Hepatitis C virus (HCV) infection is associated with decreased health-related quality of life (HRQOL). Although HCV has been suggested to directly impair neuropsychiatric functions, other factors may also play a role. PATIENTS AND METHODS: In this cross-sectional study, we assessed the impact of various host-, disease- and virus-related factors on HRQOL in a large, unselected population of anti-HCV-positive subjects. All individuals (n = 1736) enrolled in the Swiss Hepatitis C Cohort Study (SCCS) were asked to complete the Short Form 36 (SF-36) and the Hospital Anxiety Depression Scale (HADS). RESULTS: 833 patients (48%) returned the questionnaires. Survey participants had significantly worse scores in both assessment instruments when compared to a general population. By multivariable analysis, reduced HRQOL (mental and physical summary scores of SF-36) was independently associated with income. In addition, a low physical summary score was associated with age and diabetes, whereas a low mental summary score was associated with intravenous drug use. HADS anxiety and depression scores were independently associated with income and intravenous drug use. In addition, HADS depression score was associated with diabetes. None of the SF-36 or HADS scores correlated with either the presence or the level of serum HCV RNA. In particular, SF-36 and HADS scores were comparable in 555 HCV RNA-positive and 262 HCV RNA-negative individuals. CONCLUSIONS: Anti-HCV-positive subjects have decreased HRQOL compared to controls. The magnitude of this decrease was clinically important for the SF-36 vitality score. Host and environmental, rather than viral factors, seem to impact on HRQOL level.
No takes yet. Share an insight, caveat, or question.
Helbling et al. (2008) conducted a cross-sectional in Hepatitis C virus (HCV) infection (n=833). Anti-HCV-positive status vs. General population was evaluated on Health-related quality of life (HRQOL) assessed by SF-36 and HADS. Anti-HCV-positive subjects had decreased health-related quality of life compared to the general population, which was driven by host and environmental factors rather than HCV RNA positivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: